Clinical trial
Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive…
NCT00272467 · Korea Otsuka International Asia Arab, Industry · Completed
Key facts
| NCT number | NCT00272467 |
|---|---|
| Title | Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy |
| Official title | A Comparative Study on the Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy |
| Lead sponsor | Korea Otsuka International Asia Arab, Industry |
| Collaborators | Zhejiang Otsuka Pharmaceutical Co., Ltd. Industry Korea Otsuka Pharmaceutical Co., Ltd. |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Stomach Ulcer |
| Intervention type | Drug |
| Interventions | Rebamipide, Omeprazole |
| Enrollment | 132 |
| Start date | Jul 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Jan 6, 2006 |
| Last update posted | Apr 29, 2015 |
| Countries | China, South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: